sur M2Care
M2Care Secures €26 Million to Boost Healthtech Innovations
Paris, 3 September 2025 – M2care, a European Healthtech venture studio, announced the successful closure of a €26 million fundraising round. This round included a new institutional investor, the French Tech Acceleration 2 fund (FTA2), managed by Bpifrance. The funds aim to accelerate the creation and development of eight innovative healthcare projects.
M2care collaborates with early-stage ventures in healthcare, bridging academia, investors, and industry. The studio is advancing projects in cardiology, dermatology, ophthalmology, and neurology. Current investments include Previa Medical, TheraSonic, and Rhovica Neuroimaging, each focusing on innovative medical devices.
The involvement of FTA2, as part of France 2030, underscores M2care's commitment to pioneering healthcare advancements. The backing from Bpifrance reinforces efforts to enhance public health through technological innovation.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de M2Care